Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool123d agoneutral
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR TherapeuticsMotley Fool125d agobullish
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Simply Wall St.128d agoneutral
CRISPR Therapeutics (CRSP) Stock Looks Stretched On Book Value Yet Reasonable On Broader ChecksSimply Wall St.128d agobearish
CRISPR Therapeutics (CRSP) Is Up 11.3% After Broad Russell Growth Index Inclusion Has The Bull Case Changed?Stocktwits129d agobullish
CRSP, VRTX Stocks Surge As FDA Clears Casgevy For Children Ages 2 And UpMotley Fool143d agoneutral
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This YearZacks144d agobearish
CRISPR Therapeutics AG (CRSP) Ascends While Market Falls: Some Facts to NoteSimply Wall St.148d agoneutral
CRISPR Therapeutics Expands Funding Capacity As Gene Editing Pipeline AdvancesInsider Monkey156d agobullish
CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing PipelineSimply Wall St.157d agoneutral
Eli Lilly Pressure And RNA Expansion Reframe CRISPR Therapeutics OutlookMotley Fool158d agoneutral
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential